ArticleCureus2026
Goldberg-Shprintzen Megacolon Syndrome Diagnosed in the Neonatal Period: A Case Report With Molecular Confirmation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Goldberg-Shprintzen megacolon syndrome (GOSHS) is a rare autosomal recessive neurodevelopmental disorder characterized by Hirschsprung disease, microcephaly, neurodevelopmental impairment, and craniofacial dysmorphism. We report a male neonate born at 35+4 weeks of gestation who presented on day 4 of life with abdominal distension and delayed passage of meconium. Clinical examination revealed microcephaly, generalized hypotonia, craniosynostosis, and dysmorphic facial features, with a positive family history of GOSHS. Hirschsprung disease was confirmed by rectal biopsy, and cranial imaging demonstrated structural brain abnormalities, including hypoplasia of the corpus callosum, and confirmed the presence of craniosynostosis. Targeted molecular analysis of the Kinesin Family Binding Protein (KIFBP) gene using polymerase chain reaction (PCR) amplification followed by Sanger sequencing identified compound heterozygous pathogenic variants, confirming the diagnosis during the neonatal period. GOSHS should be considered in neonates presenting with Hirschsprung disease in combination with hypotonia, dysmorphic features, or neuroimaging abnormalities. Early molecular diagnosis may facilitate timely multidisciplinary management and genetic counseling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.